Zhanguo Li
Peking University People's Hospital
4
3
2
N/A
0
3
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
loic MONDOLONI
Assistance Publique Hopitaux De Marseille
Shared therapeutic areas:
Oke Anakwenze, MD
Duke Department of Orthopedic Surgery
Shared therapeutic areas:
Angelo Di Giunta, MD
Policlinico Morgagni
Shared therapeutic areas:
Scott Trenhaile, MD
OrthoIllinois
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
Jorn Steinbeck, MD
Orthopadische Praxisklinik Von Vincke
Shared therapeutic areas:
Richard Friedman, MD
Charleston Orthopaedic Associates
Shared therapeutic areas:
George Malal, MD
Bedford Hospital
Shared therapeutic areas:
Ben Sears, MD
Western Orthopaedics
Shared therapeutic areas:
Hillary Overholser
Zimmer Biomet
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
Proximod, a Selective Sphingosine-1-phosphate Receptor 1 Modulator in Patients With Moderate-to-severe Active Rheumatoid Arthritis: a Double-blind, Randomised, Placebo-controlled, Phase 2 Trial.
Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
All 4 trials loaded